Active Ingredient: ICATIBANT ACETATE
Proprietary Name: ICATIBANT ACETATE
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A213222
Product Number: 001
Approval Date: May 21, 2021
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information